SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: Dancing in the dark, zumantu, Biobillionair, HDGabor, marzan, lbwagain
Search This Board: 
Last Post: 6/24/2017 3:59:17 AM - Followers: 429 - Board type: Free - Posts Today: 3

AMARIN
Home page
VASCEPA
Savings Card Program
FDA Orange Book: VASCEPA
Amarin's Patents (Author: @lowlevelowl on StockTwits)
Trials
Marine Trial hits all EndPoints: http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=533361
Transcript MARINE trial CC: http://files.shareholder.com/downloads/AMRN/1080589559x0x430674/E6D77DA6-F44C-405F-B479-9A5C31E7A6E3/AmarinCorporation112910_Transcript.pdf
Marine Trial Presentation: http://files.shareholder.com/downloads/AMRN/1080589559x0x423194/424D45B3-62CC-4A84-81D7-F5264EF82A11/MARINE_RESULTS_Nov_29_2010.pdf
Anchor Trial completes Enrollment: http://files.shareholder.com/downloads/AMRN/1080589559x0x428546/275b9676-c0cf-4bd0-a69b-e80e26433822/AMRN_News_2010_12_16_General_Releases.pdf
Anchor Trial hits all EndPoints: http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=569648
Anchor Trial Conf Call (Apr '11):  http://www.investorcalendar.com/IC/CEPage.asp?ID=164219
Additional Marine Trial Results:  http://investor.amarincorp.com/releasedetail.cfm?ReleaseID=579260


The EPA Drug Initiative (EPADI)


AMRN SITES / QUOTES:

NASDAQ: AMRN 
Yahoo: AMRN 
Seeking Alpha: AMRN
finviz: AMRN
StreetInsider: AMRN


OTHER INFORMATION

American Heart Assocuation: 
Good vs Bad Cholesterol

Lovaza Label, etc

Excellent Blog Article featuring Lovaza data comparison - http://www.chasingthealpha.com/2010/11/amrn-look-at-tg-and-ldl-levels.html
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-654_Omacor.cfm
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021853_021654s016_omacor_toc.cfm

Various Trials, Statins/Lovaza etc:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813819/pdf/mayoclinproc_85_2_004.pdf
http://www.ncbi.nlm.nih.gov/pubmed/20877395
http://www.ncbi.nlm.nih.gov/pubmed/19002433
http://www.ncbi.nlm.nih.gov/pubmed/15250255

TriCor label, FIELD trial - http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021656s019lbl.pdf  
ACCORD trial -
http://www.endocrinetoday.com/view.aspx?rid=61934 
Jelis Trial (Japan) -
http://www.ccmdweb.org/dsl/middle.aspx?Slideid=2643&Catid=1043

transcript, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE, 10/16/2013: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM376102.pdf

AMRN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN News: Amarin Corporation plc (Nasdaq: AMRN) to Ring The Nasdaq Stock Market Opening Bell 06/12/2017 10:00:00 AM
AMRN News: Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid Parameters in Statin-Treated Women With Type 2... 06/12/2017 07:00:00 AM
AMRN News: Amarin to Present at the Jefferies 2017 Global Healthcare Conference 06/01/2017 06:00:00 AM
AMRN News: Current Report Filing (8-k) 05/19/2017 09:07:06 AM
AMRN News: Amarin Announces Expanded Research Relationships and Studies to Help Improve Cardiovascular Care 05/18/2017 06:00:00 AM
PostSubject
#101249  Sticky Note "Guess the V Day" contest #2 [(c)JL ] HDGabor 02/26/17 09:11:56 PM
#108427   L - "And how much credibility does this rafunrafun 06/24/17 03:59:17 AM
#108426   .... And how much credibility does this website Lemacred 06/24/17 02:19:50 AM
#108425   Announcement date: Looking back at the february guess Lemacred 06/24/17 02:12:06 AM
#108424   Let's see, if reduce-it fails, generics will take invest2992 06/23/17 11:36:32 PM
#108423   raf... The JELIS secondary graphs are difficult to interpret jessellivermore 06/23/17 10:07:49 PM
#108422   You need to go play around the DRYS caddiedad 06/23/17 09:26:43 PM
#108421   I think R-IT will fail, and then generics Pyrrhonian 06/23/17 09:19:07 PM
#108420   Nice finish tail on the price action today HerbieRay 06/23/17 08:41:18 PM
#108419   According to the HC wainwright report on Feb amarininvestor 06/23/17 07:52:24 PM
#108418   Are you serious ?I belive when you say james murphy 06/23/17 07:13:26 PM
#108417   A - I don't know if this is rafunrafun 06/23/17 06:48:02 PM
#108416   Chris, I couldn't disagree more :) Pyrrhonian 06/23/17 06:28:27 PM
#108415   JL - Perhaps me asking about Jelis was rafunrafun 06/23/17 05:11:31 PM
#108414   what are your thoughts on event rate over AVII77 06/23/17 05:07:56 PM
#108413   raf... read post 108210 jessellivermore 06/23/17 04:59:15 PM
#108410   Pyrr, A reduce-it continue at 80% is priced in Chris2125 06/23/17 04:38:09 PM
#108408   I calculated the EV to be about +40% Pyrrhonian 06/23/17 04:17:02 PM
#108406   P- Time will tell. The biggest factor for Biobillionair 06/23/17 04:10:14 PM
#108405   cbb... Quote: Mathew Herper (Forbes) calls the Novartis drug jessellivermore 06/23/17 04:08:00 PM
#108404   CBB... Good post...Yes Vascepa is not a very good jessellivermore 06/23/17 03:57:10 PM
#108403   raf... You may not be right, but I like jessellivermore 06/23/17 03:53:52 PM
#108402   Avi - what are your thoughts on event rafunrafun 06/23/17 03:45:42 PM
#108399   Rats. Not an investment - they're making O3's sts66 06/23/17 02:11:24 PM
#108398   I believe it was stated no "formal futility AVII77 06/23/17 02:04:16 PM
#108397   Py, assume your NPV is $1M (I doubt ggwpq 06/23/17 02:03:39 PM
#108396   The "MACD" stars are not aligned with your trade FlyFishingStocks 06/23/17 02:02:13 PM
#108395   I believe it was stated no "formal futility analysis" jfmcrr 06/23/17 01:55:39 PM
#108394   Oh stop trying to be nice, Avi poked rafunrafun 06/23/17 01:54:43 PM
#108393   Raf - No holes except that if you VuBru 06/23/17 01:52:38 PM
#108392   AV, I believe it was stated no "formal futility analysis". oneragman 06/23/17 01:45:32 PM
#108391   P- 1.) off-label promotion HDGabor 06/23/17 01:36:48 PM
#108390   Okay guys, here's my new official short call: Pyrrhonian 06/23/17 01:28:01 PM
#108389   Thanks for sharing this info on Improve-it. Per AVII77 06/23/17 01:26:52 PM
#108388   HD, BB, Pyrrhonian 06/23/17 01:21:08 PM
#108387   AVII77, Thanks for sharing this info on Improve-it. Chris2125 06/23/17 01:12:22 PM
#108386   Good info, thank you. My take is if rafunrafun 06/23/17 01:09:32 PM
#108385   AV aren't we working off these graphs from Whalatane 06/23/17 01:03:14 PM
#108384   While it is true event rate will increase jfmcrr 06/23/17 12:46:13 PM
#108383   Given what most on this board know about couldbebetter 06/23/17 12:43:01 PM
#108382   When one considers the annual cost of the couldbebetter 06/23/17 12:33:09 PM
#108381   If R-it succeeds and AZN wants to acquire invest2992 06/23/17 12:33:00 PM
#108380   Will we know if or which statin performed grbnitz4002 06/23/17 12:30:54 PM
#108379   I would like a logical dispute of my AVII77 06/23/17 12:26:05 PM
#108378   Trump is giving a speech about VA. How rafunrafun 06/23/17 12:06:01 PM
#108377   BB- AZN's STRENGTH trial makes very little sense.Well, HDGabor 06/23/17 11:50:15 AM
#108376   No, I obviously know that you were kidding, rafunrafun 06/23/17 11:46:31 AM
#108375   I was just kidding raf. Sorry. HerbieRay 06/23/17 11:43:15 AM
#108374   Really am not pumping. I would like a rafunrafun 06/23/17 11:37:22 AM
#108373   This is what I mean: rafunrafun 06/23/17 11:34:50 AM
#108372   Keep pumping raf! Its working! (Kinda sorta kidding) HerbieRay 06/23/17 11:22:24 AM
PostSubject